682 related articles for article (PubMed ID: 19531750)
21. Decreased prevalence of mixed cryoglobulinemia in the HAART era among HIV-positive, HCV-negative patients.
Kosmas N; Kontos A; Panayiotakopoulos G; Dimitrakopoulos A; Kordossis T
J Med Virol; 2006 Oct; 78(10):1257-61. PubMed ID: 16927287
[TBL] [Abstract][Full Text] [Related]
22. Cryofibrinogenemia: a marker of severity of cryoglobulinemic vasculitis.
Michaud M; Moulis G; Puissant B; Balardy L; Huart A; Gaches F; Cougoul P; Arlet P; Blancher A; Pourrat J; Sailler L
Am J Med; 2015 Aug; 128(8):916-21. PubMed ID: 25827358
[TBL] [Abstract][Full Text] [Related]
23. Initial increase in the cryoglobulin level after rituximab therapy for type II cryoglobulinemia secondary to Waldenström macroglobulinemia does not indicate failure of response.
Ghobrial IM; Uslan DZ; Call TG; Witzig TE; Gertz MA
Am J Hematol; 2004 Dec; 77(4):329-30. PubMed ID: 15551276
[TBL] [Abstract][Full Text] [Related]
24. In vitro reactivity of cryoglobulin IgM and IgG in hepatitis C virus-associated mixed cryoglobulinemia.
Schott P; Polzien F; Müller-Issberner A; Ramadori G; Hartmann H
J Hepatol; 1998 Jan; 28(1):17-26. PubMed ID: 9537859
[TBL] [Abstract][Full Text] [Related]
25. [Characterization of cryoglobulin, M protein, low molecular weight IgM in a patient with chronic hepatitis C and type II mixed cryoglobulinemia].
Nishiyama Y; Shimatsu A; Arakawa M; Nagao M; Saito A; Kido A; Koganeya H; Wada T; Okuda T; Ichiyama S
Rinsho Byori; 2001 Nov; 49(11):1139-45. PubMed ID: 11769562
[TBL] [Abstract][Full Text] [Related]
26. Clinical, biochemical, and histological changes in hepatitis C virus infection-associated cryoglobulinemia.
Fayyazi A; Schott P; Hartmann H; Mihm S; Middel P; Ramadori G; Radzun HJ
Z Gastroenterol; 1997 Oct; 35(10):921-8. PubMed ID: 9370142
[TBL] [Abstract][Full Text] [Related]
27. [Mixed cryoglobulinemia with monoclonal IgA and biclonal IgM during hepatitis C virus infection].
Abdi S; Bahji M; Essaadouni L; Agoumi N; Adnaoui M; Tazi ZM; Maaouni A
Ann Biol Clin (Paris); 2004; 62(3):334-7. PubMed ID: 15217768
[TBL] [Abstract][Full Text] [Related]
28. The etiology and pathophysiology of mixed cryoglobulinemia secondary to hepatitis C virus infection.
Agnello V
Springer Semin Immunopathol; 1997; 19(1):111-29. PubMed ID: 9266635
[TBL] [Abstract][Full Text] [Related]
29. Vascular cell adhesion molecule-1 (VCAM-1) plays a central role in the pathogenesis of severe forms of vasculitis due to hepatitis C-associated mixed cryoglobulinemia.
Kaplanski G; Maisonobe T; Marin V; Grès S; Robitail S; Farnarier C; Harlé JR; Piette JC; Cacoub P
J Hepatol; 2005 Mar; 42(3):334-40. PubMed ID: 15710215
[TBL] [Abstract][Full Text] [Related]
30. High values of CXCL10 serum levels in mixed cryoglobulinemia associated with hepatitis C infection.
Antonelli A; Ferri C; Fallahi P; Ferrari SM; Sebastiani M; Ferrari D; Giunti M; Frascerra S; Tolari S; Franzoni F; Galetta F; Marchi S; Ferrannini E
Am J Gastroenterol; 2008 Oct; 103(10):2488-94. PubMed ID: 18775023
[TBL] [Abstract][Full Text] [Related]
31. Hepatitis C virus-associated B-cell proliferation--the role of serum B lymphocyte stimulator (BLyS/BAFF).
Sène D; Limal N; Ghillani-Dalbin P; Saadoun D; Piette JC; Cacoub P
Rheumatology (Oxford); 2007 Jan; 46(1):65-9. PubMed ID: 16782735
[TBL] [Abstract][Full Text] [Related]
32. [HCV infection and mixed cryoglubulinemia].
Ignatova TM; Serov VV; Mukhin NA; Kozlovskaia LV; Milovanova SIu; Aprosina ZG
Klin Med (Mosk); 2005; 83(6):37-43. PubMed ID: 16075643
[TBL] [Abstract][Full Text] [Related]
33. Renal manifestations associated with hepatitis C virus.
Sinico RA; Fornasieri A; D'Amico G
Ann Med Interne (Paris); 2000 Feb; 151(1):41-5. PubMed ID: 10761561
[TBL] [Abstract][Full Text] [Related]
34. Murine cryoglobulinemia: pathogenic and protective IgG3 self-associating antibodies.
Berney T; Shibata T; Izui S
J Immunol; 1991 Nov; 147(10):3331-5. PubMed ID: 1940338
[TBL] [Abstract][Full Text] [Related]
35. Hepatitis C virus infection, type III cryoglobulinemia, and necrotizing vasculitis.
Brownell I; Fangman W
Dermatol Online J; 2007 Jan; 13(1):6. PubMed ID: 17511939
[TBL] [Abstract][Full Text] [Related]
36. Clinical relevance of serum cryoglobulins in hemophilic patients with hepatitis C virus infection.
Gandini G; Franchini M; Capra F; Aprili G
Ann Ital Med Int; 1999; 14(4):285-7. PubMed ID: 10638020
[TBL] [Abstract][Full Text] [Related]
37. [HCV-associated cryoglobulinemic vasculitis].
Ter Arkh; 2012; 84(5):35-42. PubMed ID: 22830210
[TBL] [Abstract][Full Text] [Related]
38. Prevalence of cryoglobulinaemia in hepatitis C virus- and hepatitis C virus/human immunodeficiency virus-infected individuals: implications for renal function.
Lapinski TW; Parfieniuk A; Rogalska-Plonska M; Czajkowska J; Flisiak R
Liver Int; 2009 Sep; 29(8):1158-61. PubMed ID: 19602133
[TBL] [Abstract][Full Text] [Related]
39. [Cryoglobulins and cryoglobulinemic vasculitis].
Suszek D; Majdan M
Wiad Lek; 2018; 71(1 pt 1):59-63. PubMed ID: 29558353
[TBL] [Abstract][Full Text] [Related]
40. [Rheumatoid factor and cryoglobulin are not efficiently related to cold activation of complement].
Nakagawa T; Ueda K; Nakajima H; Shimizu A
Rinsho Byori; 1995 Jan; 43(1):21-5. PubMed ID: 7884960
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
